|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
4420216 |
| 003 |
ICU |
| 005 |
20031020161300.0 |
| 008 |
010213s2001 nyua b 001 0 eng |
| 010 |
|
|
|a 00050083
|
| 020 |
|
|
|a 0824704169 (alk. paper)
|
| 035 |
|
|
|a CTYAFNP5898-B
|
| 035 |
|
|
|a (CtY)notisFNP5898
|
| 035 |
|
|
|a (DNLM)100966090
|
| 035 |
|
|
|a 90078012
|
| 040 |
|
|
|a DNLM
|c DNLM
|d DNLM
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 060 |
0 |
0 |
|a 2001 A-853
|
| 060 |
1 |
0 |
|a WG 300
|b A1858 2001
|
| 245 |
0 |
0 |
|a Acute coronary syndromes /
|c edited by Eric J. Topol.
|
| 250 |
|
|
|a 2nd ed., rev. and expanded.
|
| 260 |
|
|
|a New York ;
|a Basel :
|b Marcel Dekker,
|c c2001.
|
| 300 |
|
|
|a xiii, 862 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Inflammation in Acute Coronary Syndromes /
|r Mark Robbins and Eric J. Topol --
|g 2.
|t Vascular Biology of the Acute Coronary Syndromes /
|r Peter Libby, Peter Ganz and Frederick J. Schoen /
|r [et al.] --
|g 3.
|t Plaque Rupture: Pathological and Anatomical Considerations /
|r Ole Frobert, Claus S. Jorgensen and Erling Falk --
|g 4.
|t Embolization as a Pathological Mechanism /
|r Deepak L. Bhatt and Eric J. Topol --
|g 5.
|t Insights from Intravascular Ultrasound /
|r Samir R. Kapadia, E. Murat Tuzcu and Steven E. Nissen --
|g 6.
|t Differences Between Unstable Angina and Acute Myocardial Infarction: The Pathophysiological and Clinical Spectrum /
|r David J. Moliterno and Christopher B. Granger --
|g 7.
|t Acute ST-Segment Elevation Myocardial Infarction: The Open Artery and Tissue Reperfusion /
|r Steven Vanderschueren and Frans Van de Werf --
|g 8.
|t Prehospital Treatment of Acute Myocardial Infarction /
|r Kevin J. Beatt --
|g 9.
|t Thrombolysis for Acute Myocardial Infarction: First- and Second-Generation Agents /
|r Eric R. Bates --
|g 10.
|t Third-Generation Thrombolytic Agents for Acute Myocardial Infarction /
|r Sorin J. Brener and Eric J. Topol --
|g 11.
|t Combination Fibrinolysis and Platelet IIb/IIIa Antagonism for Acute Myocardial Infarction /
|r Soren J. Brener --
|g 12.
|t Diagnosis of Acute Coronary Syndromes in the Emergency Department: Evolution of Chest Pain Centers /
|r W. Brian Gibler and Andra L. Blomkalns --
|g 13.
|t The Role of the Troponins and Other Markers of Myocardial Necrosis in Risk Stratification /
|r L. Kristin Newby, Robert H. Christenson and E. Magnus Ohman --
|g 14.
|t Stenting in Acute Myocardial Infarction /
|r Steven R. Steinhubl and Eric J. Topol --
|g 15.
|t Early Invasive Versus Early Conservative Strategies for Acute Coronary Syndromes /
|r Philippe L. L'Allier and A. Michael Lincoff --
|g 16.
|t Intravenous Glycoprotein IIb/IIIa Receptor Inhibitor Agents in Ischemic Heart Disease /
|r Jeffrey Lefkovits and Eric J. Topol --
|g 17.
|t Oral Antiplatelet Agents: Aspirin, Ticlopidine, Clopidogrel, Cilostazol, and the Oral Glycoprotein IIb/IIIa Inhibitors /
|r Peter B. Berger --
|g 18.
|t Aspirin Resistance /
|r John H. Alexander and Steven R. Steinhubl --
|g 19.
|t Antithrombin Therapy in Acute Coronary Syndromes /
|r A. Vogt and K.-L. Neuhaus --
|g 20.
|t Bedside Anticoagulant Testing /
|r Christopher B. Granger and David J. Moliterno --
|g 21.
|t Bedside Platelet Monitoring /
|r Debabrata Mukherjee and David J. Moliterno --
|g 22.
|t Hypolipidemic Intervention and Plaque Stabilization /
|r Robert A. Vogel --
|g 23.
|t Myocardial Rupture: Pathobiology, Diagnosis, Medical Management, and Surgical Intervention /
|r Richard C. Becker and A. Thomas Pezzella --
|g 24.
|t Reperfusion Injury /
|r Mitchell J. Silver and John P. Gassler --
|g 25.
|t Lessons from the GUSTO Trials /
|r Vasant B. Patel and Eric J. Topol --
|g 26.
|t Treatment of Acute Myocardial Infarction: International and Regional Differences /
|r Louise Pilote --
|g 27.
|t Quality of Coronary Disease Report Cards /
|r David E. Kandzari and James G. Jollis --
|g 28.
|t Cost-Effectiveness of New Diagnostic Tools and Therapies for Acute Coronary Syndromes /
|r Eric L. Eisenstein and Daniel B. Mark.
|
| 650 |
|
0 |
|a Coronary heart disease.
|0 http://id.loc.gov/authorities/subjects/sh85032870
|
| 650 |
1 |
2 |
|a Myocardial Infarction
|x diagnosis.
|
| 650 |
1 |
2 |
|a Myocardial Infarction
|x therapy.
|
| 650 |
2 |
2 |
|a Fibrinolytic Agents
|x therapeutic use.
|
| 650 |
|
7 |
|a Coronary heart disease.
|2 fast
|0 http://id.worldcat.org/fast/fst00879535
|
| 700 |
1 |
|
|a Topol, Eric J.,
|d 1954-
|0 http://id.loc.gov/authorities/names/n87894830
|1 http://viaf.org/viaf/109428739
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)45129036
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 4cf32d3b-793e-59c8-b5d5-f523c27c5f6c
|s 3219b95e-34bf-5c8b-9fc0-3cb10d695256
|
| 928 |
|
|
|t Library of Congress classification
|a RC685.C6 A287 2001
|l JCL
|c JCL-Sci
|i 6392324
|
| 927 |
|
|
|t Library of Congress classification
|a RC685.C6 A287 2001
|l JCL
|c JCL-Sci
|e CRERAR
|b 57485008
|i 7013044
|
